| Financial Year |
March 31 2023 |
| Monetary Funds |
514,047,875.46 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
21,387,900.00 |
| Accounts Receivable |
114,743,839.61 |
| Advances to Suppliers |
40,882,948.65 |
| Other Receivables |
3,358,961.57 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
190,783,193.89 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,725,196.18 |
| Total Current Assets |
932,847,532.75 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
194,438,525.57 |
| Under-construction Projects |
5,212,349.11 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
63,090,618.78 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,382,459.49 |
| Deferred Income Tax Assets |
13,307,359.64 |
| Other Non-Current Assets |
1,183,000.00 |
| Sub-Total of Non-Current Assets |
291,338,602.21 |
| Total Assets |
1,224,186,134.96 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
127,351,476.69 |
| Accounts Payable |
40,618,763.03 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,345,835.75 |
| Taxes Payable |
2,591,897.82 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
695,430.62 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,075,686.60 |
| Other Current Liabilities |
2,335,015.93 |
| Sub-Total of Current Liabilities |
187,984,398.33 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
9,372.15 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
11,930,111.68 |
| Total Liabilities |
199,914,510.01 |
| Paid-In Capital(Or Share Stock) |
128,000,000.00 |
| Capital Surplus |
731,104,782.13 |
| Surplus Reserve |
39,770,450.49 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
125,396,392.33 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,024,271,624.95 |
| Owner's Equity（Stockholder's Equity） |
1,024,271,624.95 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,224,186,134.96 |
